Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the expulsion and continuation rate of an intruterine device (IUD) placed immediately after medical abortion.

Our hypothesis is that immediate-placement of an IUD after completed medical abortion will have a similar expulsion and continuation rate to traditional placement (4-6 weeks after pregnancy).


Clinical Trial Description

Women who seek abortion care often desire more effective or longer- lasting contraception. Intrauterine devices are as efficacious as tubal ligation, require no on-going effort on the woman's part to protect her from pregnancy, and are underutilized in the US. We are interested in determining whether placement of an intreatuereine device (IUD) at the time of confirming the completion of a medical abortion may have similar expulsion and continuation rates as IUDs placed after pregnancy (usually a 4-6 week time period). If this is the case, women may save the time and effort of yet another clinic visit, as well as have immediate protection against pregnancy after their abortion. FDA labeling does not specify or restrict time of insertion and therefore this study is in compliance with FDA labeling. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00621543
Study type Interventional
Source Boston University
Contact
Status Completed
Phase N/A
Start date March 2006
Completion date September 2008

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT02343913 - Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan N/A
Completed NCT01856777 - Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A